184 related articles for article (PubMed ID: 36422560)
1. Osmotic Pump Drug Delivery Systems-A Comprehensive Review.
Almoshari Y
Pharmaceuticals (Basel); 2022 Nov; 15(11):. PubMed ID: 36422560
[TBL] [Abstract][Full Text] [Related]
2. Osmotic pumps in drug delivery.
Verma RK; Arora S; Garg S
Crit Rev Ther Drug Carrier Syst; 2004; 21(6):477-520. PubMed ID: 15658934
[TBL] [Abstract][Full Text] [Related]
3. An overview of recent patents on oral osmotic drug delivery systems.
Kumar P; Mishra B
Recent Pat Drug Deliv Formul; 2007; 1(3):236-55. PubMed ID: 19075891
[TBL] [Abstract][Full Text] [Related]
4. Osmotic drug delivery system as a part of modified release dosage form.
Keraliya RA; Patel C; Patel P; Keraliya V; Soni TG; Patel RC; Patel MM
ISRN Pharm; 2012; 2012():528079. PubMed ID: 22852100
[TBL] [Abstract][Full Text] [Related]
5. Recent Aspects of Osmotic Pump Systems: Functionalization, Clinical use and Advanced Imaging Technology.
Chen J; Pan H; Ye T; Liu D; Li Q; Chen F; Yang X; Pan W
Curr Drug Metab; 2016; 17(3):279-91. PubMed ID: 26467064
[TBL] [Abstract][Full Text] [Related]
6. Formulation design and characterization of an elementary osmotic pump tablet of flurbiprofen.
Patel KN; Mehta TA
PDA J Pharm Sci Technol; 2014; 68(4):333-46. PubMed ID: 25035256
[TBL] [Abstract][Full Text] [Related]
7. Osmotic micropumps for drug delivery.
Herrlich S; Spieth S; Messner S; Zengerle R
Adv Drug Deliv Rev; 2012 Nov; 64(14):1617-27. PubMed ID: 22370615
[TBL] [Abstract][Full Text] [Related]
8. Long-term morphine delivery via slow release morphine pellets or osmotic pumps: Plasma concentration, analgesia, and naloxone-precipitated withdrawal.
McLane VD; Bergquist I; Cormier J; Barlow DJ; Houseknecht KL; Bilsky EJ; Cao L
Life Sci; 2017 Sep; 185():1-7. PubMed ID: 28723417
[TBL] [Abstract][Full Text] [Related]
9. Release Mechanism Between Ion Osmotic Pressure and Drug Release in Ionic-Driven Osmotic Pump Tablets (I).
Cheng L; Gao S; Ouyang D; Wang H; Wang Y; Pan W; Yang X
AAPS PharmSciTech; 2018 Feb; 19(2):803-811. PubMed ID: 29019066
[TBL] [Abstract][Full Text] [Related]
10. Mucoadhesive elementary osmotic pump tablets of trimetazidine for controlled drug delivery and reduced variability in oral bioavailability.
Alam N; Beg S; Rizwan M; Ahmad A; Ahmad FJ; Ali A; Aqil M
Drug Dev Ind Pharm; 2015 Apr; 41(4):692-702. PubMed ID: 24669975
[TBL] [Abstract][Full Text] [Related]
11. Novel osmotic pump tablet using core of drug-resin complexes for time-controlled delivery system.
Wang C; Chen F; Li JZ; Tang H; Li X; Yan KS; Ye GH; Pan WS
Yakugaku Zasshi; 2008 May; 128(5):773-82. PubMed ID: 18451626
[TBL] [Abstract][Full Text] [Related]
12. [The delivery mechanism of micro-porous osmotic pump tablets].
Zhao XL; Li Q; Gong XF; Li SM
Yao Xue Xue Bao; 2007 Feb; 42(2):226-30. PubMed ID: 17518057
[TBL] [Abstract][Full Text] [Related]
13. Effects of Dissolution Medium pH and Simulated Gastrointestinal Contraction on Drug Release From Nifedipine Extended-Release Tablets.
Gao Z; Ngo C; Ye W; Rodriguez JD; Keire D; Sun D; Wen H; Jiang W
J Pharm Sci; 2019 Mar; 108(3):1189-1194. PubMed ID: 30343136
[TBL] [Abstract][Full Text] [Related]
14. An insight to osmotic drug delivery.
Sareen R; Jain N; Kumar D
Curr Drug Deliv; 2012 May; 9(3):285-96. PubMed ID: 22452403
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in asymmetric membrane capsule based osmotic pump: a patent overview.
Patel A; Mehta T; Patel J; Patel M; Patel K; Patel N
Recent Pat Drug Deliv Formul; 2012 Apr; 6(1):66-72. PubMed ID: 22191697
[TBL] [Abstract][Full Text] [Related]
16. Formulation aspects in the development of osmotically controlled oral drug delivery systems.
Verma RK; Krishna DM; Garg S
J Control Release; 2002 Feb; 79(1-3):7-27. PubMed ID: 11853915
[TBL] [Abstract][Full Text] [Related]
17. Osmotic-controlled release oral tablets: technology and functional insights.
Ogueri KS; Shamblin SL
Trends Biotechnol; 2022 May; 40(5):606-619. PubMed ID: 34689998
[TBL] [Abstract][Full Text] [Related]
18. A novel subcutaneous infusion delivery system based on osmotic pump: in vitro and in vivo evaluation.
Gong W; Ma R; Mei D; Jing P; Dong X; Li B; Yang Y; Du L; Mei XG; Hu FQ
Drug Deliv; 2014 Feb; 21(1):1-7. PubMed ID: 24102136
[TBL] [Abstract][Full Text] [Related]
19. Three dimensional structural insight of laser drilled orifices in osmotic pump tablets.
Wu L; Wang L; Wang S; Xiao T; Chen M; Shao Q; York P; Singh V; Yin X; Gu J; Zhang J
Eur J Pharm Sci; 2016 Oct; 93():287-94. PubMed ID: 27562708
[TBL] [Abstract][Full Text] [Related]
20. [Applicability of a natural swelling matrix as the propellant of osmotic pump tablets].
Wu L; Li HY; Yin XZ; Li Y; Chen JX; Hu RF; Zhang JW
Yao Xue Xue Bao; 2013 Aug; 48(8):1319-24. PubMed ID: 24187843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]